SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001172661-22-001536
Filing Date
2022-06-17
Accepted
2022-06-17 16:04:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 deeptrack-gbt061022.htm SC 13G 101424
  Complete submission text file 0001172661-22-001536.txt   102925
Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Subject) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88976 | Film No.: 221023737
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830
Business Address 200 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830 2034090812
Deep Track Capital, LP (Filed by) CIK: 0001856083 (see all company filings)

IRS No.: 853360885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G